{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:11:37Z","timestamp":1789593097824,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015507","name":"Shandong Provincial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Reproductive Immunology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jri.2026.104940","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:40:53Z","timestamp":1785307253000},"page":"104940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Safety and efficacy of immunosuppressants for recurrent reproductive failure: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"177","author":[{"given":"Yv","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jri.2026.104940_bib1","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.biopha.2016.10.062","article-title":"Novel immunotherapeutic approaches for treatment of infertility","volume":"84","author":"Abdolmohammadi-Vahid","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jri.2026.104940_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2024.111170","article-title":"lncRNA-mediated immune system dysregulation in RIF; a comprehensive insight into immunological modifications and signaling pathways' dysregulation","volume":"85","author":"Altoum","year":"2024","journal-title":"Human. Immunol."},{"key":"10.1016\/j.jri.2026.104940_bib3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1055\/a-1056-3148","article-title":"Tacrolimus Improves the Implantation Rate in Patients with Elevated Th1\/2 Helper Cell Ratio and Repeated Implantation Failure (RIF)","volume":"80","author":"Bahrami-Asl","year":"2020","journal-title":"Geburtshilfe und Frauenheilkd."},{"key":"10.1016\/j.jri.2026.104940_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2023.104157","article-title":"Calcineurin inhibitors in the management of recurrent miscarriage and recurrent implantation failure: Systematic review and meta-analysis","volume":"160","author":"Cavalcante","year":"2023","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104940_bib5","first-page":"1637","article-title":"Efficacy of cyclosporine A combined with dydrogesterone in the treatment of unexplained recurrent spontaneous abortion and its effect on T lymphocyte subsets","volume":"23","author":"Chen","year":"2024","journal-title":"J. Clin. Exp. Med."},{"key":"10.1016\/j.jri.2026.104940_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13525","article-title":"Improved pregnancy outcomes of cyclosporine A on patients with unexplained repeated implantation failure in IVF\/ICSI cycles: A retrospective cohort study","volume":"87","author":"Cheng","year":"2022","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104940_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1017\/erm.2022.18","article-title":"TNF-\u03b1\/Anti-TNF-\u03b1 drugs and its effect on pregnancy outcomes","volume":"24","author":"Dai","year":"2022","journal-title":"Expert. Rev. Mol. Med."},{"key":"10.1016\/j.jri.2026.104940_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.reprotox.2013.11.004","article-title":"Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: a prospective, comparative, observational study","volume":"43","author":"Diav-Citrin","year":"2014","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.jri.2026.104940_bib9","first-page":"66","article-title":"Research progress of nitric oxide synthase 3 and interleukiin-1B gene polymorphisms and unexplained recurrent spontaneous abportion","volume":"33","author":"Ding","year":"2024","journal-title":"Chin. J. Human. Sex."},{"key":"10.1016\/j.jri.2026.104940_bib10","first-page":"20","article-title":"Meta-analysis of efficacy and safety of cyclosporine A in the treatment of recurrent spontaneous abortion","volume":"11","author":"Fang","year":"2021","journal-title":"Obstetrics-Gynecol. Genet.(Electron. Ed.)"},{"key":"10.1016\/j.jri.2026.104940_bib11","first-page":"441","article-title":"A randomized controlled trial of cyclosporine A in the treatment of refractory immune recurrent spontaneous abortion","volume":"32","author":"Fu","year":"2016","journal-title":"Chin. J. Pract. Gynecol. Obstet."},{"key":"10.1016\/j.jri.2026.104940_bib12","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.tjog.2019.07.007","article-title":"A randomized controlled trial of etanercept in the treatment of refractory recurrent spontaneous abortion with innate immune disorders","volume":"58","author":"Fu","year":"2019","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2026.104940_bib13","first-page":"514","article-title":"Research Progress of Cyclosporine A Treatment of Recurrent Spontaneous Abortion","volume":"40","author":"Ge","year":"2021","journal-title":"J. Int. Reprod. Health Fam. Plan."},{"key":"10.1016\/j.jri.2026.104940_bib14","first-page":"2929","article-title":"Effect of Dydrogesterone Combined with CsA in the Treatment of Unexplained Recurrent Abortion","volume":"19","author":"Guo","year":"2019","journal-title":"Progress. Mod. Biomed."},{"key":"10.1016\/j.jri.2026.104940_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1530\/RAF-21-0093","article-title":"Altered endometrial oestrogen-responsiveness and recurrent reproductive failure","volume":"3","author":"Hannan","year":"2022","journal-title":"Reprod. Fertil."},{"key":"10.1016\/j.jri.2026.104940_bib16","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ (Clin. Res. Ed. )"},{"key":"10.1016\/j.jri.2026.104940_bib17","first-page":"5","article-title":"Basic Etiology and Clinical Treatment of Immunological Recurrent Miscarriage","author":"Hong","year":"2007","journal-title":"China Med. Herald."},{"key":"10.1016\/j.jri.2026.104940_bib18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-016-8596-x","article-title":"Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review","volume":"53","author":"Jaume","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jri.2026.104940_bib19","first-page":"260","article-title":"Etanercept immunotherapy in women with a history of recurrent reproductive failure","volume":"83","author":"Jerzak","year":"2012","journal-title":"Ginekol. Pol."},{"key":"10.1016\/j.jri.2026.104940_bib20","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1111\/jcpt.13771","article-title":"Tumour necrosis factor inhibitor combined with intravenous immunoglobulin and heparin for treatment of recurrent spontaneous abortion: A two-centre, retrospective, cohort study","volume":"47","author":"Jiang","year":"2022","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.jri.2026.104940_bib21","article-title":"Evaluation of Th1-Th2 Balance in Patients With Unexplained Recurrent Spontaneous Abortion: A Systematic Review and Meta-Analysis","volume":"94","author":"Kargar","year":"2025","journal-title":"Am. J. Reprod. Immunol. (New York NY 1989)"},{"key":"10.1016\/j.jri.2026.104940_bib22","first-page":"252","article-title":"Research Progress on the Etiology of Subchorionic Hematoma","volume":"41","author":"Ke","year":"2025","journal-title":"Chin. J. Pract. Gynecol. Obstet."},{"key":"10.1016\/j.jri.2026.104940_bib23","first-page":"567","article-title":"Immunological Marker Screening and Treatment Strategy for Unexplained Recurrent Miscarriage","volume":"37","author":"Li","year":"2021","journal-title":"J. Pract. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2026.104940_bib24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00228-023-03473-9","article-title":"Tacrolimus improved the pregnancy outcomes of patients with refractory recurrent spontaneous abortion and immune bias disorders: a randomized controlled trial","volume":"79","author":"Liu","year":"2023","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jri.2026.104940_bib25","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/jcpt.13629","article-title":"Oral immunosuppressants improve pregnancy outcomes in women with idiopathic recurrent miscarriage: A meta-analysis","volume":"47","author":"Ma","year":"2022","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.jri.2026.104940_bib26","first-page":"153","article-title":"Effect of low molecular weight heparin combined with cyclosporine A for treating women with unexplained recurrent spontaneous abortion and its influence on the immune balance and hemorheology","volume":"31","author":"Ma","year":"2023","journal-title":"Chin. J. Fam. Plan."},{"key":"10.1016\/j.jri.2026.104940_bib27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/aji.12493","article-title":"Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation?","volume":"76","author":"Mekinian","year":"2016","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104940_bib28","first-page":"3","article-title":"Feasibility Analysis of Lipid Emulsion or Cyclosporine Replacement Therapy Combined with Lymphocyte Immunotherapy for Unexplained Recurrent Spontaneous Abortion","author":"Meng","year":"2020","journal-title":"Chin. Baby"},{"key":"10.1016\/j.jri.2026.104940_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1522346","article-title":"Tacrolimus (FK506) promotes placentation and maternal-fetal tolerance through modulating FASN-CEACAM1 pathway","volume":"16","author":"Meng","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jri.2026.104940_bib30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/aji.12338","article-title":"Immunosuppression with Tacrolimus Improved Reproductive Outcome of Women with Repeated Implantation Failure and Elevated Peripheral Blood Th1\/Th2 Cell Ratios","volume":"73","author":"Nakagawa","year":"2015","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104940_bib31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1741-7015-11-174","article-title":"Safety of TNF-\u03b1 inhibitors during IBD pregnancy: a systematic review","volume":"11","author":"Nielsen","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.jri.2026.104940_bib32","first-page":"n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clin. Res. Ed. )"},{"key":"10.1016\/j.jri.2026.104940_bib33","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejogrb.2014.07.038","article-title":"Immunomodulators to treat recurrent miscarriage","volume":"181","author":"Prins","year":"2014","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.jri.2026.104940_bib34","first-page":"152","article-title":"Effect and safety of immunotherapy on pregnancy outcome in patients with RPL","volume":"40","author":"RU","year":"2024","journal-title":"Chin. J. Immunol."},{"key":"10.1016\/j.jri.2026.104940_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.repbio.2021.100480","article-title":"Endometrial preparation with etanercept increased embryo implantation and live birth rates in women suffering from recurrent implantation failure during IVF","volume":"21","author":"Santiago","year":"2021","journal-title":"Reprod. Biol."},{"key":"10.1016\/j.jri.2026.104940_bib36","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/jog.15500","article-title":"Co-administration of tacrolimus and low molecular weight heparin in patients with a history of implantation failure and elevated peripheral blood natural killer cell proportion","volume":"49","author":"Shen","year":"2023","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.jri.2026.104940_bib37","first-page":"1077","article-title":"Effect of Dydrogesterone Combined with CsA in the Treatment of Unexplained Recurrent Abortion","volume":"57","author":"Song","year":"2022","journal-title":"Jiangxi Med. J."},{"key":"10.1016\/j.jri.2026.104940_bib38","first-page":"56","article-title":"Effects of cyclosporine A combined with active lymphocyte immunotherapy on serum T cell subsets,hormone levels and ACA levels in patients with URSA","volume":"43","author":"Sun","year":"2021","journal-title":"J. Youjiang Med. Univ. Natl."},{"key":"10.1016\/j.jri.2026.104940_bib39","article-title":"Role of inflammatory factors in the etiology and treatment of recurrent implantation failure","volume":"22","author":"Wang","year":"2022","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.jri.2026.104940_bib40","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/bcp.12642","article-title":"Pregnancy outcome after TNF-\u03b1 inhibitor therapy during the first trimester: a prospective multicentre cohort study","volume":"80","author":"Weber-Schoendorfer","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jri.2026.104940_bib41","first-page":"8","article-title":"Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion","volume":"60","author":"Winger","year":"2008","journal-title":"Am. J. Reprod. Immunol. (New York NY 1989)"},{"key":"10.1016\/j.jri.2026.104940_bib42","first-page":"1919","article-title":"Clinical Study on the Treatment of Recurrent Miscarriage with Cyclosporine Soft Capsules Combined with Zishen Yutai Pills","volume":"34","author":"Wu","year":"2023","journal-title":"Mod. Diagn. Treat."},{"key":"10.1016\/j.jri.2026.104940_bib43","first-page":"122","article-title":"The Effect of Dalteparin Sodium Combined with Cyclosporine A on the Treatment of Unexplained Recurrent Miscarriage and Its Impact on the Immune Microenvironment","volume":"22","author":"Xu","year":"2024","journal-title":"J. China Prescr. Drug."},{"key":"10.1016\/j.jri.2026.104940_bib44","first-page":"1562","article-title":"Evaluation of the therapeutic effect of cyclosporine A combined with fat emulsion in the treatment of recurrent abortion","volume":"18","author":"Zhang","year":"2018","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.jri.2026.104940_bib45","article-title":"Efficacy of Intrauterine Perfusion of Cyclosporin A for Intractable Recurrent Spontaneous Abortion Patients With Endometrial Alloimmune Disorders: A Randomized Controlled Trial","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jri.2026.104940_bib46","first-page":"253","article-title":"Effects of Cyclosporine A on Clinical Outcomes, Th1\/2\/17 Cytokines, and D-Dimer in Recurrent Spontaneous Abortion Patients with Increased Natural Killer Cells","volume":"19","author":"Zhao","year":"2024","journal-title":"J. Chengdu Med. Coll."}],"container-title":["Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037826001099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037826001099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:00:40Z","timestamp":1789592440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165037826001099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":46,"alternative-id":["S0165037826001099"],"URL":"https:\/\/doi.org\/10.1016\/j.jri.2026.104940","relation":{},"ISSN":["0165-0378"],"issn-type":[{"value":"0165-0378","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of immunosuppressants for recurrent reproductive failure: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Reproductive Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jri.2026.104940","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104940"}}